HOME >> BIOLOGY >> NEWS
University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.

The University of Colorados Technology Transfer Office has executed two licenses with Quidel Corporation of San Diego, CA, a leading provider of rapid point-of-care (POC) diagnostic tests. The agreements grant exclusive, worldwide rights to two influenza detection technologies developed by researchers at the University of Colorado at Boulder.

The Anti-Viral Resistance (AVR) Chip was developed by a team of CU-Boulder researchers led by Drs. Kathy Rowlen and Robert Kuchta. Quidels intent is to develop and market diagnostic tests featuring the chip for use in identifying mutations that may complicate influenza treatment decisions.

The chip detects the two most common factors contributing to the resistance of influenza to drug treatment. The ability to identify antiviral susceptibility is important for global monitoring of influenza patterns, and for directing physicians toward better treatment decisions.

Preliminary studies demonstrate a 95% success rate in the detection of influenza mutations known to result in drug resistance.

The BChip was also developed at CU-Boulder, in close collaboration with the U.S. Centers for Disease Control and Prevention (CDC); its primary application is in influenza B monitoring, as a tool for the clinical laboratory and at the point-of-care in the physician office laboratory. The BChip can detect two influenza B virus strains (B/Victoria/2/87 and B/Yamagata/16/88), which are critical in determining seasonal influenza vaccines.

In a recent study of 62 influenza B virus samples from 19 countries, dating from 1945 to 2005, as well as five negative control samples, the BChip exhibited 97% sensitivity and 100% specificity, with no false positives.

The two new chips help strengthen Quidels technology foundation in molecular diagnostics; they represent further work done on the FluChip and MChip technologies licensed by Quidel from CU in December 2006.

After many year
'"/>

Contact: Lindsay Polak
lindsay.polak@cu.edu
303-735-5518
University of Colorado at Boulder
17-Jul-2007


Page: 1 2

Related biology news :

1. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer
4. $9M grant awarded to University of Cincinnati for bipolar disorder research
5. University of Leeds strengthens China links in membrane and neurobiology
6. Manchester University helps with pharaoh DNA analysis
7. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
8. University of Arizona launches major scientific research initiative at Biosphere 2
9. Link between obesity and enlarged heart discovered by University of Arizona researchers
10. Bee researcher at Arizona State University is 1 of 20 new Pew Scholars in the biomedical sciences
11. University of Pittsburgh School of Medicine researchers develop off-the-shelf vascular grafts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... SHANGHAI (PRWEB) , ... August 24, 2020 , ... ... approaches for the treatment of chronic inflammatory and fibrotic diseases, today announced that ... Vice President of Drug Discovery. , Dr. Canan previously served as Executive Director ...
(Date:8/23/2020)... THE WOODLANDS, Texas (PRWEB) , ... August 21, ... ... from Rigaku Corporation has been published and is now available ... on single crystal X-ray diffraction—serves the X-ray analysis community, presenting current news and ...
(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners Chairman ... Operations executive with expertise in clinical trial planning and feasibility, regulatory inspection readiness, ... Consultant. Throughout his career, Mr. Movahhed has helped design and manage oncology, neurology, ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... BINGHAM FARMS, Mich. (PRWEB) , ... August 12, ... ... International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... R3 Stem ... injections for only $3950. With 50 million stem cells total, patients may choose which ... cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ... a strategic partnership whereby Catalent will provide support for the development, manufacturing, and ...
(Date:7/22/2020)... , ... July 22, 2020 , ... Join experts from ... Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar on ... regulating body in China for drugs and medical devices. Specifically, for medical devices, the ...
Breaking Biology Technology:
Cached News: